Semiconductor materials provider ATMI Inc. reached a global distribution agreement with Finesse Solutions LLC to market an integrated bioreactor platform using Finesse's T700 control systems.
The deal gives ATMI the right to sell Finesse T700 control systems with the ATMI single-use Integrity PadReactor system. Finesse manufactures measurement and control solutions for bioprocess applications.
The integrated bioreactor system can be purchased from ATMI in a single transaction with follow-on application and technical support from both ATMI and Finesse.
Under the terms of the agreement, ATMI will offer fully-integrated bioreactors for the production of recombinant proteins or vaccines. Additionally, ATMI will provide all post point-of-sale customer support for PadReactor hardware and disposables while Finesse will support the controller, sensors, and software.
For more information, visit http://www.atmi.com.